These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Effects of scopolamine on autonomic profiles underlying motion sickness susceptibility. Uijtdehaage SH; Stern RM; Koch KL Aviat Space Environ Med; 1993 Jan; 64(1):1-8. PubMed ID: 8424733 [TBL] [Abstract][Full Text] [Related]
4. Prevention of experimental motion sickness by scopolamine absorbed through the skin. Graybiel A; Knepton J; Shaw J Aviat Space Environ Med; 1976 Oct; 47(10):1096-100. PubMed ID: 791234 [TBL] [Abstract][Full Text] [Related]
5. Is there a role for nonsedating antihistamines in motion sickness? Fallout from space research may soon benefit your patients. Kohl RL J Respir Dis; 1991 Apr; 12(4 Suppl):S17-21. PubMed ID: 11542203 [TBL] [Abstract][Full Text] [Related]
6. The effect of antimotion sickness drugs on habituation to motion. Wood CD; Manno JE; Manno BR; Odenheimer RC; Bairnsfather LE Aviat Space Environ Med; 1986 Jun; 57(6):539-42. PubMed ID: 3718377 [TBL] [Abstract][Full Text] [Related]
7. Rotation at 30 RPM about the A axis after 6 hours in the 10 degree head-down position: effect on susceptibility to motion sickness. Graybiel A; Lackner JR Aviat Space Environ Med; 1979 Apr; 50(4):390-2. PubMed ID: 464962 [TBL] [Abstract][Full Text] [Related]
8. High dose ondansetron for reducing motion sickness in highly susceptible subjects. Muth ER; Elkins AN Aviat Space Environ Med; 2007 Jul; 78(7):686-92. PubMed ID: 17679566 [TBL] [Abstract][Full Text] [Related]
9. [Effect of experimental motion sickness on postrotatory nystagmus and the illusion of counterrotation]. Aĭzikov GS; Kliushnikova ON Kosm Biol Aviakosm Med; 1985; 19(2):89-91. PubMed ID: 3990240 [No Abstract] [Full Text] [Related]
10. Human assay of antimotion sickness drugs. Graybiel A; Wood CD; Knepton J; Hoche JP; Perkins GF Aviat Space Environ Med; 1975 Sep; 46(9):1107-18. PubMed ID: 1100039 [TBL] [Abstract][Full Text] [Related]
11. Therapeutic effects of antimotion sickness medications on the secondary symptoms of motion sickness. Wood CD; Stewart JJ; Wood MJ; Manno JE; Manno BR; Mims ME Aviat Space Environ Med; 1990 Feb; 61(2):157-61. PubMed ID: 2178599 [TBL] [Abstract][Full Text] [Related]
12. Experimental assessment of selected antimotion drugs. Matsnev EI; Bodo D Aviat Space Environ Med; 1984 Apr; 55(4):281-6. PubMed ID: 6732678 [TBL] [Abstract][Full Text] [Related]
13. What you thought you knew about motion sickness isn't necessarily so. Cowings PS; Malmstrom FV Flying Saf; 1984 Feb; 40(2):12-7. PubMed ID: 11540877 [TBL] [Abstract][Full Text] [Related]
14. [Effect of kavinton on the hemodynamics and adenosine metabolism in atherosclerosis patients]. Mikunis RI; Serkova VK; Zhebel' VN Vrach Delo; 1988 Jul; (7):27-9. PubMed ID: 3188457 [No Abstract] [Full Text] [Related]
15. The effect of a vincamine derivative on vegetative reactions provoked by labyrinth stimulation. Bodó G; Hartmann J Ther Hung; 1979; 27(4):182-4. PubMed ID: 538749 [No Abstract] [Full Text] [Related]
16. Chlorpheniramine and ephedrine in combination for motion sickness. Buckey JC; Alvarenga DL; MacKenzie TA J Vestib Res; 2007; 17(5-6):301-11. PubMed ID: 18626140 [TBL] [Abstract][Full Text] [Related]
17. [Evaluation of the effect of anti-motion sickness pharmaceuticals on adaptation to the model conditions of long-term rotation]. Orlov OI Aviakosm Ekolog Med; 2007; 41(6):24-8. PubMed ID: 18350832 [TBL] [Abstract][Full Text] [Related]
18. A double-blind placebo controlled evaluation of acupressure in the treatment of motion sickness. Warwick-Evans LA; Masters IJ; Redstone SB Aviat Space Environ Med; 1991 Aug; 62(8):776-8. PubMed ID: 1930060 [TBL] [Abstract][Full Text] [Related]